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Hypoxanthine - guanine phosphoribosyltransferase 
(HPRT) is a purine salvage enzyme that catalyzes the con- 
version of hypoxanthine to inosine monophosphate and gua- 
nine to guanosine monophosphate. Previous studies of mu- 
tant HPRT proteins analyzed at the molecular level have 
shown a significant heterogeneity. This investigation fur- 
ther verifies this heterogeneity and identifies insertions, 
deletions, and point mutations. The direct sequencing of 
the polymerase chain reaction-amplified product of re- 
verse-transcribed HPRT mRNA enabled the rapid identifi- 
cation of the mutations found in 17 previously uncharac- 
terized cell lines derived from patients with the Lesch-Ny- 
han syndrome. 0 1991 Academic Press, Inc. 
Hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) deficiency is an inherited disorder that re- 
sults in the overproduction of uric acid. Complete de- 
ficiency is associated with the devastating Lesch-Ny- 
han syndrome (Lesch and Nyhan, 1964; Seegmiller et 
al., 1967). The gene encoding for the HPRT protein is 
over 44 kb and consists of nine exons and eight in- 
trons (Pate1 et al., 1984). The HPRT mRNA, which 
encodes for the protein, is about 1400 bp. 
Multiple samples of cytoplasmic RNA were iso- 
lated from lymphoblast and fibroblast cell lines. The 
mRNA was reverse-transcribed using standard pro- 
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cedures (Ausubel et aZ., 1987). The HPRT-specific 
primers for PCR amplification and direct sequencing 
were previously reported by our laboratory (Davidson 
et al., 1989b). The entire coding region was sequenced 
in both directions and RNase A mapping or direct 
sequencing of amplified genomic DNA was used to 
confirm these mutations (Gibbs and Caskey, 1987). 
HPRT activity was measured in all cell lines using the 
standard radioisotopic assay (Holden and Kelley, 
1978). The activity of all cell lines was virtually unde- 
tectable (~0.1% of normal controls). 
A total of 17 cell lines representing 16 unrelated 
individuals were sequenced. We identified 10 point 
mutations, four deletions, and three insertions (Table 
1). The insertions and deletions, three of which have 
not been described (1266,1656, and 1650), predict pre- 
maturely terminated translation products. The three 
insertional events in 1266, 1656, and 1650 might be 
explained by strand slippage, as each of the mutations 
occurs in repetitive tracts of deoxynucleotides 
(d(G*dT),, d(T),, and d(G),, respectively). The in- 
sertion described in 1650 has been reported 
previously in a different, unrelated cell line, RJK 866 
(Gibbs et aZ., 1989). Two of the point mutations are 
nonsense mutations that prematurely terminate 
translation. The remaining 8 point mutations cause 
single amino acid changes. The nucleotide changes in 
1151, 1265, 1734, and 779 have not been previously 
described. 
Although six of the point mutations cause a C to T 
(or G to A) change, only the mutations in 754-4 and 
1321 are in the CpG context and thus may be indica- 
tive of hot spots for mutation in the HPRT gene 
(Green et al., 1990; Koeberl et aZ., 1990; Perutz, 1990). 
Interestingly, these two mutations have been de- 
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Nucleotide Amino acid 
mutation alteration 
Point mutations 
1151 G, + A (1)” Met, + Ile 
1265 C 14s + ‘I’ (3) Ala, + Val 
754-4 C 151 + T (3) Arg,, + stop 
955-2 G 209 .-, A (3) QY,, + Glu 
1510 G 209 -, A (3) GUY,, + Glu 
1522 C 222 + A (3) Pb4 + Leu 
375 T, -, A (5) V43o + Asp 
1321 C so8 + T (7) Arg,,, + stop 
1734 T,, --+ C (8) Ilelm + Thr 
779 Am--* G (9) Hisso + Arg 
Deletions 
1052 Exon 4 Premature termination 
17576 Exon 4 Premature termination 
1758’ Exon 4 Premature termination 
1423 AATT 80-83’ (2) ATms 
Insertions 
1650 Gm-md (3) Premature termination 
1656 Tm-4,: (6) Premature termination 
1266 GT,,,-d (7) Premature termination 
“The number in parentheses refers to the exon in which the 
mutation is found. 
* Cell lines 1757 and 1758 are derived from siblings. 
c The exact position of this deletion could be 80-82 or 81-83. 
d The exact position is unclear; insertion could be at 206 to 211. 
e The exact position is unclear; insertion could be at 435 to 437. 
f The exact position is unclear; insertion could be at 511 to 512, 
514 to 515,516 to 517. 
scribed previously in the unrelated patients 
HPRTshefford and HPRTNoah Mymms, respectively (Da- 
vidson et al., 1991). 
The heterogeneity found in previously published 
mutant HPRT protein and nucleic acid studies was 
also shown in this study at the nucleotide level (Wil- 
son et al., 1986, Gibbs et al., 1989, 1990; Davidson et 
al., 1989a, 1991). Although the mutations identified to 
date are mostly unique, there is a pattern of cluster- 
ing. Evidence from previous studies suggests that mu- 
tations occur in discrete regions in the coding se- 
quence, including the putative substrate binding sites 
(Hershey and Taylor, 1986). Review of our compiled 
data shows strong support for this clustering phenom- 
enon (Davidson et aZ., 1989a,b, 1991). Of the point 
mutations found thus far, approximately 40% occur 
in exon 3 in two regions of only 6 bp. One area con- 
tains 38% of all exon 3 mutations, while the other has 
30%. Exon 5 has 11% of the mutations and yet en- 
codes for only 3% of the protein. Similarly, these mu- 
tations also occur within an &base region. 
The eight point mutations identified in this report, 
which predict a single amino acid substitution, are of 
special interest in the study of the HPRT protein’s 
structural properties required for catalytic compe- 
tence. These mutations may indicate important areas 
that either are involved with the tertiary structure of 
the protein or are required for catalysis. Further pro- 
tein structure studies are necessary before the exact 
mechanisms causing enzyme dysfunction can be un- 
derstood. 
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